SCHEMBL10243365

SCHEMBL10243365

Cc1ccc(S(=O)(=O)N(CC(=O)Nc2ccc(C(=O)O)c(O)c2)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
STAT5B P51692 2/20 0.62
STAT3 P40763 3/20 0.58
CTDSP1 Q9GZU7 1/20 0.58
SIRT5 Q9NXA8 1/20 0.58
LMNA P02545 3/20 0.45
MAPK1 P28482 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MCL1 Q07820 2/20 0.45
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 3/20 0.42
THRB P10828 1/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15215027 0.91 STAT5B (0.54) STAT5BSTAT3CTDSP1SIRT5LMNA
SCHEMBL10247637 0.77 STAT5B (1.00) STAT5BSTAT3
SCHEMBL4456216 0.74 STAT3 (1.00) STAT3CTDSP1SIRT5MCL1KMT2A
SCHEMBL31249645 0.74 STAT3 (1.00) STAT3CTDSP1SIRT5MCL1KMT2A
SCHEMBL10243359 0.74 STAT3 (0.76) STAT5BSTAT3
SCHEMBL12359540 0.73 STAT3 (0.67) STAT3CTDSP1SIRT5LMNASMN1; SMN2
SCHEMBL12359433 0.72 STAT3 (0.94) STAT3CTDSP1SIRT5MCL1KMT2A
SCHEMBL10243757 0.71 STAT3 (1.00) STAT5BSTAT3
SCHEMBL2187189 0.70 KMT2A (0.54) STAT3CTDSP1SIRT5MAPK1SMN1; SMN2
SCHEMBL30338918 0.70 KMT2A (0.54) STAT3CTDSP1SIRT5MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196373-B2 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2019-02-05 US disclosed
US-20150038708-A1 SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-02-05 US disclosed
US-8846707-B2 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein UNIVERISTY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-09-30 US disclosed
WO-2012018868-A1 SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEINS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038708-A1 SUBSTITUTED 2-HYDROXY-4-(2-(PHENYLSULFONAMIDO)ACETAMIDO)BENZOIC ACID ANALOGS AS INHIBITORS OF STAT PROTEIN STAT3, STAT1, STAT4 STAT5B 5/4885STAT3 1/4885CTDSP1 651/4885
US-10196373-B2 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein STAT3, STAT1, STAT4 STAT5B 5/4885STAT3 1/4885CTDSP1 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.